ATIR101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ATIR101, covering 2021-01-12 to 2022-05-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of ATIR101 as Adjunctive Treatment to Blood Stem Cell Transplantation From a Haploidentical Family Donor Compared to Post-transplant Cyclophosphamide in Patients With Blood Cancer [Phase 3]